Clinical Trial Update: Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children

View source ↗

Summary

A completed clinical trial evaluating whether intra-arterial carboplatin causes hearing loss in children with intraocular retinoblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Retinoblastoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intraocular Retinoblastoma, Hearing Loss | Status: COMPLETED